Diamante Srl

📍 Verona, Italy🗓 Founded 2016👥 18 employees💰 Last funded Jul 2022
Biotechnology Research🌐 diamante.tech
Website LinkedIn
DIAMANTE (Nano-Technologies for Autoimmune Disease) is a biotech company focused on the use of plants for producing high value-added molecules. The company was funded in 2016 with the development of new tools in autoimmune disease diagnosis and now we are growing approaching therapeutics applications. As an innovation-oriented female company, our value proposition is the creation of novel therapeutic approach for autoimmune diseases based on the restoration of self-tolerance, using plant viruses displaying immunodominant peptides. Diamante, thanks to the Regione Veneto and particularly though the national grant POR FESR AZIONE 1.1.1 2020/2021, has achieved important results in the diagnostic field for the Rheumatoid Arthritis (RA). This project allowed the company to increase the team with two more specialized people and to develop a specific technology platform for the RA diagnoses.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in Diamante Srl?
Diamante Srl has 1 investors on record on gritt.io and 1 late-stage investors.
When did Diamante Srl last raise funding?
The most recent investment in Diamante Srl recorded on gritt.io was in July 2022.
When was Diamante Srl founded?
Diamante Srl was founded in 2016.
What industry is Diamante Srl in?
Diamante Srl operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Diamante Srl based?
Diamante Srl is headquartered in Verona, Italy.